Thyroid Gland Disorders Treatment Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : January 2022
  • Region: Worldwide
  • Country: Other
  • Report ID : 5027

  • Format: PPT, PDF

Thyroid Gland Disorders Treatment Market: Segmented by Route of Administration, Disease Type, Distribution Channel, Drug Type – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5027 Categories: ,

Report Description of the Thyroid Gland Disorders Treatment Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Thyroid Gland Disorders Treatment Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Thyroid Gland Disorder Treatment.
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

Thyroid Gland Disorders Treatment Market Executive Summary

Thyroid Disorder Treatment Market size was valued at USD 2.16 Billion in 2020 and is projected to reach USD 2.78 Billion by 2028, growing at a CAGR of 3.17% from 2021 to 2028.

Increase in disposable income, lifestyle changes, increasing instances of thyroid and increase in awareness pertaining to healthcare are some of the factors anticipated to foster market growth during the forecast period. The Global Thyroid Disorder Treatment Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Market Size and Key Findings

The Thyroid Gland Disorders Treatment Market size stood at around USD 2.16 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 3.17% during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

This study identifies the increasing demand for levothyroxine as one of the prime reasons driving the thyroid gland disorder treatment market growth during the next few years.

Increasing demand for levothyroxine will lead to sizable demand in the market.

Market Restraints

The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder. However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period.

COVID-19 impact on “Thyroid Gland Disorder Treatment Market” 

As the effect of COVID-19 spreads, the overall market has been impacted by COVID-19 and the growth rate has also been impacted in 2019-2020. Our latest research, perspectives, and insights on the management issues that matter most to the companies and organization about the market, which is leading through the COVID-19 crisis to managing risk and digitizing operations to deliver trusted information and experiences to the decision makers.

Competitive Landscape

Key Players

The market for Thyroid Gland Disorder Treatment is moderately competitive and majorly consists of the global players. With the rising innovations in the therapeutics, it is believed that some small or mid-sized companies will be entering the market in the coming future.

The reports cover key developments in as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from The Global thyroid gland disorder treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for The global thyroid gland disorder treatment market in the global market. Below mentioned is the list of few companies engaged in The Global thyroid gland disorder treatment market.

  • Abbott
  • AbbVie Inc.
  • Merck KGaA
  • Mylan N.V.
  • Pfizer, Inc.
  • Amgen Inc
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sanofi S.A.
  • Aspen

Notable Recent Deals

The report analyzes factors affecting The global thyroid gland disorder treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting The Global thyroid gland disorder treatment market in these regions.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The thyroid is a gland or an organ in the human body responsible for the secretion of hormones. It plays a vital role in the growth and metabolic activities of the human body. The vital function of the thyroid gland is to secrete hormones and regulate the functions in the human body.  There are mainly three hormones which are secreted by the thyroid gland.

  1. Triiodothyronine which is commonly known as T3.
  2. Tetraiodothyronine which is also known as T4.
  3. Calcitonin

Health insurance providers such as Bharti AXA, Max Bupa have come up with a wide range of health insurance plans covering thyroid disorders. The benefits availed from these plans will give the policyholder a sigh of relief during the tough time of thyroid diagnosis and treatment.

1. Report Description of the Thyroid Gland Disorders Treatment Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Thyroid Gland Disorders Treatment Market Executive Summary
2.1 Thyroid Gland Disorders Treatment Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of Thyroid Gland Disorders Treatment Market
3.1 Market Growth Drivers Analysis
3.1.1 Increase in incidence of thyroid gland disorders of Chronic Diseases
3.1.2 Development of effective combination thyroid disorders drug therapies
3.1.3 Increase in number of disease awareness programs in developing regions
3.2 Market Restraints Analysis
3.2.1 Side effects that cause lesser patient adherence
3.2.2 Stringent government regulations
3.3 Covid-19 Market Impact Analysis
4. Thyroid Gland Disorder Market Segmentation
4.1 By ROUTE OF ADMINISTRATION
4.1.1 Oral
4.1.2 Intravenous route
4.1.3 Others
4.2 By DISEASE TYPE
4.2.1 Hypothyroidism
4.2.2 Hyperthyroidism
4.3 BY DISTRIBUTION CHANNEL
4.3.1 Wholesaler/Distributor Retailer Mail-order Pharmacy Others
4.3.2 Retailer
4.3.3 Mail-Order Pharmacy
4.3.4 Others
4.4 By DRUG TYPE
4.4.1 Levothyroxine
4.4.2 Liothyronine
4.4.3 Propylthiouracil
4.4.4 Imidazole-based compounds
4.4.5 Others
5 Thyroid Gland Disorder Treatment Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.2 Major Top Market Players
6.3 Products in Pipeline
6.4 R&D Initiatives in Thyroid Gland Disorder Treatment Market
6.5 Notable recent deals in Thyroid Gland Disorder Treatment Market
6.5.1 Joint Ventures
6.5.2 Partnerships
6.5.3 Mergers & Acquisitions
6.5.4 Strategic divestments
7 Key Company Profiles
7.1 Abbott Laboratories Company overview
Product & Services, Strategies & Financials
7.2 AbbVie Inc Company overview
Product & Services, Strategies & Financials
7.3 Allergan Plc Company overview
Product & Services, Strategies & Financials
7.4 GlaxoSmithKline plc Company overview
Product & Services, Strategies & Financials
7.5 Lannett Company, Inc Company overview
Product & Services, Strategies & Financials
7.6 Merck & Co. Inc Company overview
Product & Services, Strategies & Financials
7.7 Novartis AG Company overview
Product & Services, Strategies & Financials
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9 Factors Driving Future Growth
9.1 New Trends and Development of Thyroid Gland Disorder Treatment market
9.2 Future Opportunities
10 Strategic Recommendations

Thyroid Gland Disorders Treatment Market Segmentation

By ROUTE OF ADMINISTRATION

Based on Route of Administration, The market is bifurcated into Oral, Intravenous and Others segments. The Oral segment is anticipated to account for the highest market share. This can be attributed to the benefits provided such as-ease during administration, high efficacy and minimum invasion. Product R&D is anticipated to result in innovative and more effective medicines, which is anticipated to drive the market further.

By DISEASE TYPE

Based on Indication, The market is bifurcated into Hypothyroidism, and Hyperthyroidism segments. Hypothyroidism is anticipated to account for the highest market share. This can be attributed to the fact that the majority of instances among people suffering from thyroid were of Hypothyroidism. Levothyroxine, a hormone replacement drug, held the largest share.

By DISTRIBUTION CHANNEL

Based on Distribution Channel, The market is bifurcated into Wholesaler/Distributor, Retail Chain, Online Distribution, and Other Distribution Channel segments. Wholesaler/Distributor segments is anticipated to account for the largest market share. This can be attributed to the fact that they always have the stock of medicines available, and provide discounts on bulk purchases. The online Distribution segment is anticipated to be the fastest-growing segment, owing to the increasing popularity of E-Commerce and benefits provided like the ease of delivery and discounts offered during sale season.

By DRUG TYPE

The major drug classes used to treat hypothyroidism are Liothyronine and Levothyroxine. Of these, Levothyroxine, a hormone replacement drug, held the dominant revenue share in 2016 and is expected to maintain its position throughout the forecast period. Brand names of this drug class in the U.S. are Levoxyl, Tirosint, and Synthroid; companies manufacturing generic equivalents for this drug class are Mylan; Merck KGaA; and Lannett Company, Inc

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements